Seattle-area health data company Truveta announced a partnership Tuesday with biopharma giant Pfizer, which will use Truveta’s platform to monitor the safety of their COVID vaccines and therapies across the U.S. Truveta has access to de-identified data from 20 health systems, representing more than 15% of U.S. healthcare. The company also released data from a recent analysis of COVID-19, suggesting that women are more susceptible to long COVID, consistent with previous studies.  

Source